Related Experiment Video
Updated: Aug 3, 2026
12:01
Induction of Protein Deletion Through In Utero Electroporation to Define Deficits in Neuronal Migration in Transgenic Models
Published on: January 12, 2015
Primidone-induced embryolethality and DRL deficits in surviving offspring
W J Pizzi1, A S Newman, A Shansky
1Neuropsychology Laboratory, Northeastern Illinois University, Chicago 60625, USA. w-pizzi@neiu.edu
Neurotoxicology and Teratology
|March 25, 1998
Summary
Prenatal exposure to primidone (PRM) was embryolethal in rats. Surviving offspring exhibited behavioral impairments, including learning deficits in males and altered activity patterns in females.
Area of Science:
- Neurobehavioral teratology
- Developmental toxicology
- Pharmacology
Background:
- Primidone (PRM) is an anticonvulsant medication.
- The effects of prenatal PRM exposure on offspring development and behavior are not fully understood.
- Understanding drug effects during gestation is crucial for maternal and child health.
Purpose of the Study:
- To investigate the developmental and behavioral consequences of prenatal primidone exposure in Sprague-Dawley rats.
- To assess the embryolethal effects and potential learning or activity impairments in offspring.
Main Methods:
- Pregnant rats received oral primidone (120 mg/kg) or a vehicle control from gestation days 8-20.
- Evaluated dam weight, birth weight, pregnancy maintenance, and implantation sites.
- Assessed offspring behavior, including exploratory activity and learning acquisition using a DRL-20 operant schedule.
Main Results:
- Primidone exposure significantly reduced pregnancy maintenance (43% vs. 100% in controls), indicating embryolethality.
- No differences in dam weight or offspring birth weight were observed.
- Prenatal PRM exposure led to impaired learning acquisition in males and abolished sex-specific activity increases in females.
Conclusions:
- Prenatal primidone exposure is embryolethal in rats at the tested dose.
- Surviving offspring exhibit specific behavioral deficits, including learning impairments and altered activity patterns.
- These findings highlight potential risks associated with primidone use during pregnancy.
